KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Acetaminophen Hepatotoxicity in Humans and Mice

    Thumbnail
    View/Open
    McGill_ku_0099D_12684_DATA_1.pdf (5.526Mb)
    Issue Date
    2013-05-31
    Author
    McGill, Mitchell Ryan
    Publisher
    University of Kansas
    Format
    210 pages
    Type
    Dissertation
    Degree Level
    Ph.D.
    Discipline
    Pharmacology, Toxicology & Therapeutics
    Rights
    This item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.
    Metadata
    Show full item record
    Abstract
    Acetaminophen (APAP) is a popular analgesic and antipyretic. Most of a therapeutic dose is glucuronidated or sulfated and excreted. A small amount is converted by cytochromes P450 to the reactive electrophile N-acetyl-p-benzoquinone imine (NAPQI). Fortunately, NAPQI can be detoxified by conjugation with glutathione (GSH). However, after an overdose the glucuronidation and sulfation pathways are overwhelmed, resulting in formation of excess NAPQI which depletes GSH and binds proteins. This causes mitochondrial dysfunction and oxidative stress. Oxidative stress activates the c-Jun N-terminal kinase, which translocates to mitochondria and exacerbates the injury. The result is hepatocyte death. Though well-established in mice, less work has been done with human models. Our goal was to further investigate the role of mitochondria in mice and to begin studying the mechanisms of hepatotoxicity in humans. A comparison of rats and mice supported the role of mitochondria in mice. Using the human liver cell line HepaRG, we found that protein binding, loss of mitochondrial potential, and oxidative stress preceded injury. Finally, using novel mechanistic plasma biomarkers, we have provided evidence that mitochondrial damage may also occur in APAP overdose patients, leading to oncotic necrosis. Recently, it was proposed that serum APAP-protein adducts can be used to diagnose APAP overdose. However, little work has been done to characterize the dose-response and timecourse of this parameter. We found that liver GSH depletion isn't required for protein binding in mice and that binding occurred without toxicity. Importantly, APAP-protein adducts could be measured in plasma without liver injury. The mechanism by which this occurs likely involves secretion of proteins adducted within hepatocytes, though other mechanisms couldn't be ruled out. Finally, liver injury caused by ischemia-reperfusion increased APAP-protein adducts in mouse plasma after a subtoxic dose. Our data support the use of APAP-protein adducts in plasma, but urge consideration of potential confounding factors.
    URI
    http://hdl.handle.net/1808/12178
    Collections
    • Dissertations [4474]
    • Pharmacy Dissertations and Theses [118]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps